fanta.bio Sample: CNhs11835
17089 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1050 / 13414 (7.8%) | 369 / 134140 (0.3%) | −324.0 | −324.0 | 28.46 |
| HIF1A SRX11007095 | HK-2 Kidney | 2079 / 13414 (15.5%) | 781 / 134140 (0.6%) | −324.0 | −324.0 | 26.62 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1512 / 13414 (11.3%) | 636 / 134140 (0.5%) | −324.0 | −324.0 | 23.77 |
| TP53 SRX19538279 | Osteoblasts Bone | 499 / 13414 (3.7%) | 223 / 134140 (0.2%) | −324.0 | −324.0 | 22.38 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1458 / 13414 (10.9%) | 679 / 134140 (0.5%) | −324.0 | −324.0 | 21.47 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 1990 / 13414 (14.8%) | 985 / 134140 (0.7%) | −324.0 | −324.0 | 20.20 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 2043 / 13414 (15.2%) | 1022 / 134140 (0.8%) | −324.0 | −324.0 | 19.99 |
| SCML2 SRX644728 | 293 Kidney | 1181 / 13414 (8.8%) | 671 / 134140 (0.5%) | −324.0 | −324.0 | 17.60 |
| FOXP1 SRX736067 | LNCAP Prostate | 1562 / 13414 (11.6%) | 985 / 134140 (0.7%) | −324.0 | −324.0 | 15.86 |
| MYH11 SRX265221 | ME-1 Blood | 756 / 13414 (5.6%) | 532 / 134140 (0.4%) | −324.0 | −324.0 | 14.21 |
| BRD4 SRX9419937 | BT-474 Breast | 3081 / 13414 (23.0%) | 2393 / 134140 (1.8%) | −324.0 | −324.0 | 12.88 |
| MED1 SRX9419944 | BT-474 Breast | 3019 / 13414 (22.5%) | 2346 / 134140 (1.7%) | −324.0 | −324.0 | 12.87 |
| BRD4 SRX9419935 | BT-474 Breast | 3079 / 13414 (23.0%) | 2394 / 134140 (1.8%) | −324.0 | −324.0 | 12.86 |
| MED1 SRX9419945 | BT-474 Breast | 3066 / 13414 (22.9%) | 2388 / 134140 (1.8%) | −324.0 | −324.0 | 12.84 |
| BRD4 SRX9419936 | BT-474 Breast | 3127 / 13414 (23.3%) | 2476 / 134140 (1.8%) | −324.0 | −324.0 | 12.63 |
| BRD4 SRX9419938 | BT-474 Breast | 3096 / 13414 (23.1%) | 2480 / 134140 (1.8%) | −324.0 | −324.0 | 12.48 |
| MED1 SRX9419946 | BT-474 Breast | 3115 / 13414 (23.2%) | 2511 / 134140 (1.9%) | −324.0 | −324.0 | 12.41 |
| MED1 SRX9419947 | BT-474 Breast | 3020 / 13414 (22.5%) | 2435 / 134140 (1.8%) | −324.0 | −324.0 | 12.40 |
| EZH2 SRX2146136 | LNCAP Prostate | 6576 / 13414 (49.0%) | 6707 / 134140 (5.0%) | −324.0 | −324.0 | 9.80 |
| BRD4 SRX736201 | 90-8TL Neural | 5007 / 13414 (37.3%) | 5364 / 134140 (4.0%) | −324.0 | −324.0 | 9.33 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 1537 / 13414 (11.5%) | 2242 / 134140 (1.7%) | −324.0 | −324.0 | 6.86 |
| HIF1A SRX20663235 | HK-2 Kidney | 478 / 13414 (3.6%) | 231 / 134140 (0.2%) | −317.6 | −314.4 | 20.69 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1217 / 13414 (9.1%) | 2947 / 134140 (2.2%) | −311.7 | −308.5 | 4.13 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 1426 / 13414 (10.6%) | 4060 / 134140 (3.0%) | −305.9 | −302.8 | 3.51 |
| TP53 SRX19538274 | U2OS Bone | 400 / 13414 (3.0%) | 148 / 134140 (0.1%) | −287.5 | −284.3 | 27.03 |
| TP53 SRX19538276 | U2OS Bone | 394 / 13414 (2.9%) | 140 / 134140 (0.1%) | −286.2 | −283.1 | 28.14 |
| TP53 SRX19538268 | U2OS Bone | 396 / 13414 (3.0%) | 147 / 134140 (0.1%) | −284.3 | −281.2 | 26.94 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 618 / 13414 (4.6%) | 740 / 134140 (0.6%) | −273.8 | −270.8 | 8.35 |
| PBX4 SRX2731658 | PC-3 Prostate | 744 / 13414 (5.5%) | 20912 / 134140 (15.6%) | −265.4 | −262.4 | 0.36 |
| TP53 SRX19538280 | Osteoblasts Bone | 387 / 13414 (2.9%) | 174 / 134140 (0.1%) | −262.8 | −259.8 | 22.24 |
| TP53 SRX19538267 | U2OS Bone | 361 / 13414 (2.7%) | 129 / 134140 (0.1%) | −261.8 | −258.8 | 27.98 |
| TP53 SRX19538275 | U2OS Bone | 365 / 13414 (2.7%) | 136 / 134140 (0.1%) | −261.7 | −258.7 | 26.84 |
| AGO2 SRX4708039 | Hep G2 Liver | 1657 / 13414 (12.4%) | 6016 / 134140 (4.5%) | −255.4 | −252.4 | 2.75 |
| TP53 SRX19538281 | Osteoblasts Bone | 409 / 13414 (3.0%) | 236 / 134140 (0.2%) | −255.4 | −252.4 | 17.33 |
| TP53 SRX19538273 | U2OS Bone | 349 / 13414 (2.6%) | 127 / 134140 (0.1%) | −251.8 | −248.9 | 27.48 |
| IRF3 SRX11453858 | Hep G2 Liver | 301 / 13414 (2.2%) | 66 / 134140 (0.0%) | −243.6 | −240.7 | 45.61 |
| TP53 SRX19538269 | U2OS Bone | 434 / 13414 (3.2%) | 334 / 134140 (0.2%) | −241.3 | −238.4 | 12.99 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 368 / 13414 (2.7%) | 186 / 134140 (0.1%) | −240.6 | −237.7 | 19.78 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 558 / 13414 (4.2%) | 759 / 134140 (0.6%) | −227.8 | −224.9 | 7.35 |
| YAP1 SRX757325 | H2052 Lung | 516 / 13414 (3.8%) | 16154 / 134140 (12.0%) | −227.5 | −224.6 | 0.32 |
| FOS SRX150477 | MCF 10A Breast | 503 / 13414 (3.7%) | 15615 / 134140 (11.6%) | −217.1 | −214.2 | 0.32 |
| TP53 SRX19538270 | U2OS Bone | 403 / 13414 (3.0%) | 340 / 134140 (0.3%) | −214.8 | −211.9 | 11.85 |
| FOS SRX150478 | MCF 10A Breast | 530 / 13414 (4.0%) | 15939 / 134140 (11.9%) | −213.9 | −211.0 | 0.33 |
| YAP1 SRX757326 | H2052 Lung | 452 / 13414 (3.4%) | 14405 / 134140 (10.7%) | −205.0 | −202.1 | 0.31 |
| FOXA1 SRX4815198 | MCF-7 Breast | 773 / 13414 (5.8%) | 19261 / 134140 (14.4%) | −203.8 | −200.9 | 0.40 |
| TP53 SRX19538282 | Osteoblasts Bone | 353 / 13414 (2.6%) | 249 / 134140 (0.2%) | −203.7 | −200.8 | 14.18 |
| IRF3 SRX11453861 | Hep G2 Liver | 257 / 13414 (1.9%) | 64 / 134140 (0.0%) | −202.8 | −200.0 | 40.16 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 484 / 13414 (3.6%) | 14847 / 134140 (11.1%) | −202.7 | −199.9 | 0.33 |
| BRD4 SRX736204 | 90-8TL Neural | 849 / 13414 (6.3%) | 2187 / 134140 (1.6%) | −201.0 | −198.2 | 3.88 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 524 / 13414 (3.9%) | 812 / 134140 (0.6%) | −195.2 | −192.4 | 6.45 |
| TP53 SRX19538271 | U2OS Bone | 566 / 13414 (4.2%) | 982 / 134140 (0.7%) | −193.5 | −190.7 | 5.76 |
| ESR1 SRX4367193 | MCF-7 Breast | 773 / 13414 (5.8%) | 18828 / 134140 (14.0%) | −191.7 | −188.8 | 0.41 |
| FOXA1 SRX176862 | MCF-7 Breast | 283 / 13414 (2.1%) | 11100 / 134140 (8.3%) | −190.6 | −187.8 | 0.25 |
| Epitope tags SRX10549776 | K-562 Blood | 1189 / 13414 (8.9%) | 4161 / 134140 (3.1%) | −190.6 | −187.8 | 2.86 |
| ESR1 SRX371478 | MCF-7 Breast | 272 / 13414 (2.0%) | 10890 / 134140 (8.1%) | −190.2 | −187.4 | 0.25 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 1213 / 13414 (9.0%) | 4319 / 134140 (3.2%) | −189.3 | −186.5 | 2.81 |
| FOXA1 SRX4815197 | MCF-7 Breast | 573 / 13414 (4.3%) | 15757 / 134140 (11.7%) | −188.5 | −185.8 | 0.36 |
| BRD1 SRX286203 | RKO Digestive tract | 1029 / 13414 (7.7%) | 3273 / 134140 (2.4%) | −188.5 | −185.7 | 3.14 |
| FOS SRX4192880 | MCF 10A Breast | 381 / 13414 (2.8%) | 12684 / 134140 (9.5%) | −187.5 | −184.8 | 0.30 |
| ESR1 SRX7624157 | MCF-7 Breast | 619 / 13414 (4.6%) | 16372 / 134140 (12.2%) | −186.1 | −183.4 | 0.38 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 249 / 13414 (1.9%) | 10290 / 134140 (7.7%) | −184.0 | −181.2 | 0.24 |
| BRPF3 SRX796085 | RKO Digestive tract | 937 / 13414 (7.0%) | 2844 / 134140 (2.1%) | −182.3 | −179.5 | 3.29 |
| ESR1 SRX20282961 | MCF-7 Breast | 280 / 13414 (2.1%) | 10740 / 134140 (8.0%) | −180.5 | −177.8 | 0.26 |
| FOXA1 SRX3931044 | MCF-7 Breast | 517 / 13414 (3.9%) | 14590 / 134140 (10.9%) | −179.4 | −176.7 | 0.35 |
| ESR1 SRX371469 | MCF-7 Breast | 226 / 13414 (1.7%) | 9714 / 134140 (7.2%) | −178.9 | −176.2 | 0.23 |
| FOXA1 SRX176863 | MCF-7 Breast | 275 / 13414 (2.1%) | 10559 / 134140 (7.9%) | −177.6 | −174.9 | 0.26 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 260 / 13414 (1.9%) | 10271 / 134140 (7.7%) | −176.9 | −174.2 | 0.25 |
| ESR1 SRX176860 | MCF-7 Breast | 388 / 13414 (2.9%) | 12444 / 134140 (9.3%) | −176.6 | −173.9 | 0.31 |
| ESR1 SRX371479 | MCF-7 Breast | 196 / 13414 (1.5%) | 9046 / 134140 (6.7%) | −175.2 | −172.5 | 0.22 |
| RUNX1 SRX2513054 | 293 Kidney | 2587 / 13414 (19.3%) | 14164 / 134140 (10.6%) | −174.7 | −172.0 | 1.83 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 153 / 13414 (1.1%) | 8184 / 134140 (6.1%) | −174.5 | −171.8 | 0.19 |
| ESR1 SRX20282960 | MCF-7 Breast | 260 / 13414 (1.9%) | 10131 / 134140 (7.6%) | −172.3 | −169.6 | 0.26 |
| FOXA1 SRX1161177 | MCF-7 Breast | 228 / 13414 (1.7%) | 9548 / 134140 (7.1%) | −172.1 | −169.4 | 0.24 |
| KAT7 SRX101303 | RKO Digestive tract | 1138 / 13414 (8.5%) | 4133 / 134140 (3.1%) | −171.8 | −169.1 | 2.75 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 409 / 13414 (3.0%) | 12583 / 134140 (9.4%) | −170.4 | −167.8 | 0.33 |
| GATA3 SRX190239 | MCF-7 Breast | 351 / 13414 (2.6%) | 11592 / 134140 (8.6%) | −169.0 | −166.4 | 0.30 |
| ESR1 SRX7624156 | MCF-7 Breast | 391 / 13414 (2.9%) | 12249 / 134140 (9.1%) | −169.0 | −166.3 | 0.32 |
| FOS SRX150517 | MCF 10A Breast | 416 / 13414 (3.1%) | 12640 / 134140 (9.4%) | −168.6 | −166.0 | 0.33 |
| AGO2 SRX6783957 | Hep G2 Liver | 1049 / 13414 (7.8%) | 3655 / 134140 (2.7%) | −168.4 | −165.8 | 2.87 |
| ESR1 SRX176861 | MCF-7 Breast | 399 / 13414 (3.0%) | 12354 / 134140 (9.2%) | −168.3 | −165.7 | 0.32 |
| AR SRX10820653 | LNCAP Prostate | 278 / 13414 (2.1%) | 174 / 134140 (0.1%) | −168.3 | −165.7 | 15.98 |
| AR SRX1067071 | LHSAR Prostate | 483 / 13414 (3.6%) | 13646 / 134140 (10.2%) | −167.1 | −164.5 | 0.35 |
| FOXA1 SRX371482 | MCF-7 Breast | 351 / 13414 (2.6%) | 11520 / 134140 (8.6%) | −166.9 | −164.3 | 0.30 |
| BRPF3 SRX796084 | RKO Digestive tract | 1249 / 13414 (9.3%) | 4893 / 134140 (3.6%) | −166.7 | −164.1 | 2.55 |
| BRPF3 SRX796086 | RKO Digestive tract | 1209 / 13414 (9.0%) | 4651 / 134140 (3.5%) | −166.2 | −163.6 | 2.60 |
| ESR1 SRX1531791 | MCF-7 Breast | 222 / 13414 (1.7%) | 9263 / 134140 (6.9%) | −166.2 | −163.6 | 0.24 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 345 / 13414 (2.6%) | 11396 / 134140 (8.5%) | −166.1 | −163.5 | 0.30 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 1675 / 13414 (12.5%) | 7720 / 134140 (5.8%) | −165.9 | −163.3 | 2.17 |
| ESR1 SRX371471 | ZR-75-1 Breast | 257 / 13414 (1.9%) | 9869 / 134140 (7.4%) | −165.3 | −162.7 | 0.26 |
| ESR1 SRX371470 | ZR-75-1 Breast | 208 / 13414 (1.6%) | 8970 / 134140 (6.7%) | −165.0 | −162.5 | 0.23 |
| ESR1 SRX20282939 | MCF-7 Breast | 272 / 13414 (2.0%) | 10102 / 134140 (7.5%) | −164.5 | −161.9 | 0.27 |
| KAT6A SRX20971022 | Fibroblasts Others | 219 / 13414 (1.6%) | 70 / 134140 (0.1%) | −163.4 | −160.8 | 31.29 |
| FOXA1 SRX371483 | MCF-7 Breast | 273 / 13414 (2.0%) | 10071 / 134140 (7.5%) | −162.8 | −160.2 | 0.27 |
| FOXA1 SRX1161176 | MCF-7 Breast | 228 / 13414 (1.7%) | 9266 / 134140 (6.9%) | −162.6 | −160.0 | 0.25 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 1439 / 13414 (10.7%) | 6194 / 134140 (4.6%) | −162.5 | −160.0 | 2.32 |
| FOXA1 SRX371481 | MCF-7 Breast | 258 / 13414 (1.9%) | 9711 / 134140 (7.2%) | −159.7 | −157.2 | 0.27 |
| JUNB SRX8488088 | SUM 229PE Breast | 495 / 13414 (3.7%) | 13568 / 134140 (10.1%) | −159.7 | −157.1 | 0.36 |
| ESR1 SRX371467 | MCF-7 Breast | 252 / 13414 (1.9%) | 9596 / 134140 (7.2%) | −159.4 | −156.9 | 0.26 |
| ESR1 SRX194569 | MCF-7 Breast | 249 / 13414 (1.9%) | 9535 / 134140 (7.1%) | −159.1 | −156.6 | 0.26 |
| RELA SRX2207672 | HUVEC Cardiovascular | 1036 / 13414 (7.7%) | 21193 / 134140 (15.8%) | −158.5 | −156.0 | 0.49 |
| RELA SRX2207673 | HUVEC Cardiovascular | 959 / 13414 (7.1%) | 20155 / 134140 (15.0%) | −158.4 | −155.8 | 0.48 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 311 / 13414 (2.3%) | 10569 / 134140 (7.9%) | −158.0 | −155.5 | 0.29 |
| ESR1 SRX20282972 | MCF-7 Breast | 271 / 13414 (2.0%) | 9881 / 134140 (7.4%) | −157.8 | −155.3 | 0.27 |
| 5-mC SRX882970 | LNCAP Prostate | 2250 / 13414 (16.8%) | 12081 / 134140 (9.0%) | −157.6 | −155.1 | 1.86 |
| ING5 SRX286202 | RKO Digestive tract | 1098 / 13414 (8.2%) | 4110 / 134140 (3.1%) | −157.5 | −155.0 | 2.67 |
| AR SRX1067070 | LHSAR Prostate | 640 / 13414 (4.8%) | 15635 / 134140 (11.7%) | −157.0 | −154.5 | 0.41 |
| ESR1 SRX194572 | MCF-7 Breast | 138 / 13414 (1.0%) | 7371 / 134140 (5.5%) | −156.5 | −154.0 | 0.19 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 321 / 13414 (2.4%) | 10681 / 134140 (8.0%) | −156.3 | −153.8 | 0.30 |
| AGO2 SRX6783958 | Hep G2 Liver | 1009 / 13414 (7.5%) | 3595 / 134140 (2.7%) | −156.3 | −153.8 | 2.81 |
| ESR1 SRX20282954 | MCF-7 Breast | 269 / 13414 (2.0%) | 9759 / 134140 (7.3%) | −155.1 | −152.6 | 0.28 |
| FOS SRX150476 | MCF 10A Breast | 449 / 13414 (3.3%) | 12695 / 134140 (9.5%) | −154.9 | −152.4 | 0.35 |
| ESR1 SRX371468 | MCF-7 Breast | 144 / 13414 (1.1%) | 7433 / 134140 (5.5%) | −154.5 | −152.0 | 0.19 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 373 / 13414 (2.8%) | 11451 / 134140 (8.5%) | −153.8 | −151.3 | 0.33 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 579 / 13414 (4.3%) | 14605 / 134140 (10.9%) | −153.3 | −150.8 | 0.40 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 237 / 13414 (1.8%) | 9128 / 134140 (6.8%) | −152.8 | −150.4 | 0.26 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 224 / 13414 (1.7%) | 8882 / 134140 (6.6%) | −152.4 | −149.9 | 0.25 |
| FOXA1 SRX1161173 | MCF-7 Breast | 195 / 13414 (1.5%) | 8337 / 134140 (6.2%) | −151.9 | −149.4 | 0.23 |
| TLE3 SRX4815191 | MCF-7 Breast | 245 / 13414 (1.8%) | 9234 / 134140 (6.9%) | −151.7 | −149.2 | 0.27 |
| GATA3 SRX190194 | SK-N-SH Neural | 634 / 13414 (4.7%) | 15305 / 134140 (11.4%) | −150.4 | −148.0 | 0.41 |
| FOXA1 SRX1161175 | MCF-7 Breast | 182 / 13414 (1.4%) | 8045 / 134140 (6.0%) | −150.3 | −147.8 | 0.23 |
| 5-mC SRX882968 | LNCAP Prostate | 2206 / 13414 (16.4%) | 11956 / 134140 (8.9%) | −150.2 | −147.7 | 1.85 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 226 / 13414 (1.7%) | 8820 / 134140 (6.6%) | −149.2 | −146.8 | 0.26 |
| ESR1 SRX371476 | MCF-7 Breast | 188 / 13414 (1.4%) | 8098 / 134140 (6.0%) | −148.3 | −145.8 | 0.23 |
| TP53 SRX19538272 | U2OS Bone | 473 / 13414 (3.5%) | 911 / 134140 (0.7%) | −148.0 | −145.6 | 5.19 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 378 / 13414 (2.8%) | 549 / 134140 (0.4%) | −147.3 | −144.8 | 6.89 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 220 / 13414 (1.6%) | 104 / 134140 (0.1%) | −147.1 | −144.6 | 21.15 |
| ESR1 SRX10365536 | MCF-7 Breast | 119 / 13414 (0.9%) | 6715 / 134140 (5.0%) | −147.0 | −144.6 | 0.18 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 526 / 13414 (3.9%) | 1149 / 134140 (0.9%) | −146.8 | −144.3 | 4.58 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 639 / 13414 (4.8%) | 15185 / 134140 (11.3%) | −145.3 | −142.9 | 0.42 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 646 / 13414 (4.8%) | 15283 / 134140 (11.4%) | −145.3 | −142.8 | 0.42 |
| RAC1 SRX10365541 | MCF-7 Breast | 121 / 13414 (0.9%) | 6704 / 134140 (5.0%) | −145.1 | −142.7 | 0.18 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 228 / 13414 (1.7%) | 8730 / 134140 (6.5%) | −145.1 | −142.7 | 0.26 |
| ESR1 SRX371475 | BT-474 Breast | 109 / 13414 (0.8%) | 6445 / 134140 (4.8%) | −144.9 | −142.5 | 0.17 |
| FOXA1 SRX1787653 | MCF-7 Breast | 202 / 13414 (1.5%) | 8249 / 134140 (6.1%) | −144.7 | −142.3 | 0.24 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 932 / 13414 (6.9%) | 3309 / 134140 (2.5%) | −144.6 | −142.3 | 2.82 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 348 / 13414 (2.6%) | 10740 / 134140 (8.0%) | −144.6 | −142.2 | 0.32 |
| RAC1 SRX10365543 | MCF-7 Breast | 123 / 13414 (0.9%) | 6725 / 134140 (5.0%) | −144.5 | −142.2 | 0.18 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 661 / 13414 (4.9%) | 15469 / 134140 (11.5%) | −144.5 | −142.1 | 0.43 |
| FOS SRX4192879 | MCF 10A Breast | 298 / 13414 (2.2%) | 9889 / 134140 (7.4%) | −143.8 | −141.4 | 0.30 |
| GATA3 SRX176864 | MCF-7 Breast | 188 / 13414 (1.4%) | 7959 / 134140 (5.9%) | −143.7 | −141.3 | 0.24 |
| ESR1 SRX10365535 | MCF-7 Breast | 203 / 13414 (1.5%) | 8231 / 134140 (6.1%) | −143.6 | −141.2 | 0.25 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 255 / 13414 (1.9%) | 9148 / 134140 (6.8%) | −143.4 | −141.0 | 0.28 |
| CEBPB SRX150632 | HeLa Uterus | 621 / 13414 (4.6%) | 14849 / 134140 (11.1%) | −143.3 | −141.0 | 0.42 |
| FOXA1 SRX100454 | T-47D Breast | 344 / 13414 (2.6%) | 10625 / 134140 (7.9%) | −143.1 | −140.7 | 0.32 |
| LEO1 SRX1873456 | SEM Blood | 1186 / 13414 (8.8%) | 4911 / 134140 (3.7%) | −142.7 | −140.4 | 2.41 |
| YAP1 SRX5718140 | 293 Kidney | 465 / 13414 (3.5%) | 12510 / 134140 (9.3%) | −142.6 | −140.3 | 0.37 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 436 / 13414 (3.3%) | 797 / 134140 (0.6%) | −142.6 | −140.2 | 5.47 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 1321 / 13414 (9.8%) | 5816 / 134140 (4.3%) | −141.8 | −139.4 | 2.27 |
| GATA3 SRX5057632 | MCF-7 Breast | 164 / 13414 (1.2%) | 7416 / 134140 (5.5%) | −140.6 | −138.2 | 0.22 |
| ESR1 SRX20282955 | MCF-7 Breast | 282 / 13414 (2.1%) | 9504 / 134140 (7.1%) | −140.2 | −137.8 | 0.30 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 106 / 13414 (0.8%) | 6247 / 134140 (4.7%) | −140.0 | −137.7 | 0.17 |
| CIC SRX13262055 | Astrocytes Neural | 2348 / 13414 (17.5%) | 13343 / 134140 (9.9%) | −140.0 | −137.7 | 1.76 |
| JUN SRX4192884 | MCF 10A Breast | 209 / 13414 (1.6%) | 8234 / 134140 (6.1%) | −140.0 | −137.7 | 0.25 |
| SMARCA2 SRX8119677 | MeT-5A Others | 452 / 13414 (3.4%) | 12204 / 134140 (9.1%) | −139.5 | −137.2 | 0.37 |
| ESR1 SRX4367192 | MCF-7 Breast | 564 / 13414 (4.2%) | 13876 / 134140 (10.3%) | −139.5 | −137.1 | 0.41 |
| VGLL1 SRX24602130 | BT-20 Breast | 275 / 13414 (2.1%) | 9360 / 134140 (7.0%) | −139.4 | −137.0 | 0.29 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 206 / 13414 (1.5%) | 8157 / 134140 (6.1%) | −139.3 | −137.0 | 0.25 |
| ESR1 SRX20282940 | MCF-7 Breast | 292 / 13414 (2.2%) | 9635 / 134140 (7.2%) | −139.0 | −136.7 | 0.30 |
| ESR1 SRX10365532 | MCF-7 Breast | 131 / 13414 (1.0%) | 6719 / 134140 (5.0%) | −138.7 | −136.3 | 0.19 |
| TEAD1 SRX3401272 | MCF-7 Breast | 192 / 13414 (1.4%) | 7865 / 134140 (5.9%) | −138.1 | −135.8 | 0.24 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 519 / 13414 (3.9%) | 1190 / 134140 (0.9%) | −138.0 | −135.7 | 4.36 |
| FOXA1 SRX3923514 | MCF-7 Breast | 277 / 13414 (2.1%) | 9351 / 134140 (7.0%) | −138.0 | −135.7 | 0.30 |
| AR SRX10820651 | LNCAP Prostate | 278 / 13414 (2.1%) | 272 / 134140 (0.2%) | −137.6 | −135.3 | 10.22 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 1512 / 13414 (11.3%) | 7214 / 134140 (5.4%) | −137.5 | −135.2 | 2.10 |
| TCF12 SRX190356 | SK-N-SH Neural | 769 / 13414 (5.7%) | 16710 / 134140 (12.5%) | −137.4 | −135.1 | 0.46 |
| ARID1A SRX5089376 | MCF-7 Breast | 229 / 13414 (1.7%) | 8488 / 134140 (6.3%) | −136.9 | −134.6 | 0.27 |
| ESR1 SRX371474 | BT-474 Breast | 106 / 13414 (0.8%) | 6159 / 134140 (4.6%) | −136.8 | −134.5 | 0.17 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 377 / 13414 (2.8%) | 604 / 134140 (0.5%) | −136.8 | −134.5 | 6.24 |
| ESR1 SRX20282973 | MCF-7 Breast | 324 / 13414 (2.4%) | 10090 / 134140 (7.5%) | −136.7 | −134.4 | 0.32 |
| Epitope tags DRX443510 | 293 Kidney | 1170 / 13414 (8.7%) | 4921 / 134140 (3.7%) | −136.6 | −134.4 | 2.38 |
| ESR1 SRX2881000 | MCF-7 Breast | 231 / 13414 (1.7%) | 8513 / 134140 (6.3%) | −136.5 | −134.2 | 0.27 |
| ESR1 SRX330067 | MCF-7 Breast | 240 / 13414 (1.8%) | 8648 / 134140 (6.4%) | −135.8 | −133.5 | 0.28 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 466 / 13414 (3.5%) | 12273 / 134140 (9.1%) | −135.6 | −133.3 | 0.38 |
| TP53 SRX396254 | Fibroblasts Others | 718 / 13414 (5.4%) | 2220 / 134140 (1.7%) | −135.4 | −133.1 | 3.23 |
| ESR1 SRX2881002 | MCF-7 Breast | 256 / 13414 (1.9%) | 8907 / 134140 (6.6%) | −135.4 | −133.1 | 0.29 |
| FOXA1 SRX1161174 | MCF-7 Breast | 283 / 13414 (2.1%) | 9359 / 134140 (7.0%) | −135.1 | −132.8 | 0.30 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 209 / 13414 (1.6%) | 8075 / 134140 (6.0%) | −135.0 | −132.7 | 0.26 |
| ESR1 SRX1012629 | MCF-7 Breast | 156 / 13414 (1.2%) | 7096 / 134140 (5.3%) | −134.8 | −132.6 | 0.22 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 723 / 13414 (5.4%) | 2256 / 134140 (1.7%) | −134.7 | −132.4 | 3.20 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 485 / 13414 (3.6%) | 12525 / 134140 (9.3%) | −134.5 | −132.3 | 0.39 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 959 / 13414 (7.1%) | 19141 / 134140 (14.3%) | −133.9 | −131.7 | 0.50 |
| 5-mC SRX882965 | LNCAP Prostate | 1800 / 13414 (13.4%) | 9376 / 134140 (7.0%) | −133.6 | −131.3 | 1.92 |
| ESR1 SRX20282953 | MCF-7 Breast | 216 / 13414 (1.6%) | 8145 / 134140 (6.1%) | −133.3 | −131.0 | 0.27 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 186 / 13414 (1.4%) | 7608 / 134140 (5.7%) | −133.2 | −131.0 | 0.24 |
| ESR1 SRX20282946 | MCF-7 Breast | 150 / 13414 (1.1%) | 6928 / 134140 (5.2%) | −133.1 | −130.8 | 0.22 |
| FOXA2 SRX3230382 | Hep G2 Liver | 376 / 13414 (2.8%) | 10784 / 134140 (8.0%) | −132.8 | −130.5 | 0.35 |
| STAT5B SRX831881 | CD8+ T cells Blood | 219 / 13414 (1.6%) | 137 / 134140 (0.1%) | −132.7 | −130.4 | 15.99 |
| SREBF2 SRX5359048 | HCC70 Breast | 1328 / 13414 (9.9%) | 6068 / 134140 (4.5%) | −131.9 | −129.7 | 2.19 |
| ESR1 SRX330069 | MCF-7 Breast | 160 / 13414 (1.2%) | 7081 / 134140 (5.3%) | −131.7 | −129.5 | 0.23 |
| ESR1 SRX1012632 | MCF-7 Breast | 122 / 13414 (0.9%) | 6336 / 134140 (4.7%) | −131.6 | −129.3 | 0.19 |
| ESR1 SRX2943591 | MCF-7 Breast | 188 / 13414 (1.4%) | 7591 / 134140 (5.7%) | −131.5 | −129.2 | 0.25 |
| ESR1 SRX20282971 | MCF-7 Breast | 272 / 13414 (2.0%) | 9054 / 134140 (6.7%) | −131.4 | −129.2 | 0.30 |
| ESR1 SRX3110725 | MCF-7 Breast | 246 / 13414 (1.8%) | 8603 / 134140 (6.4%) | −131.2 | −129.0 | 0.29 |
| PGR SRX1012655 | MCF-7 Breast | 164 / 13414 (1.2%) | 7136 / 134140 (5.3%) | −131.1 | −128.9 | 0.23 |
| MEAF6 DRX234811 | 293 Kidney | 1322 / 13414 (9.9%) | 6044 / 134140 (4.5%) | −131.1 | −128.8 | 2.19 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 303 / 13414 (2.3%) | 9548 / 134140 (7.1%) | −130.9 | −128.7 | 0.32 |
| ESR1 SRX330070 | MCF-7 Breast | 131 / 13414 (1.0%) | 6495 / 134140 (4.8%) | −130.8 | −128.6 | 0.20 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 1514 / 13414 (11.3%) | 7385 / 134140 (5.5%) | −130.7 | −128.5 | 2.05 |
| FOXA1 SRX11222441 | MCF-7 Breast | 208 / 13414 (1.6%) | 7898 / 134140 (5.9%) | −129.8 | −127.6 | 0.26 |
| FOXA1 SRX371480 | MCF-7 Breast | 190 / 13414 (1.4%) | 7559 / 134140 (5.6%) | −129.2 | −127.0 | 0.25 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 254 / 13414 (1.9%) | 8679 / 134140 (6.5%) | −129.2 | −127.0 | 0.29 |
| FOXA1 SRX3931043 | MCF-7 Breast | 290 / 13414 (2.2%) | 9268 / 134140 (6.9%) | −128.9 | −126.7 | 0.31 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 653 / 13414 (4.9%) | 1949 / 134140 (1.5%) | −128.8 | −126.6 | 3.35 |
| ESR1 SRX10365558 | MCF-7 Breast | 183 / 13414 (1.4%) | 7410 / 134140 (5.5%) | −128.7 | −126.4 | 0.25 |
| TLE3 SRX4815192 | MCF-7 Breast | 256 / 13414 (1.9%) | 8686 / 134140 (6.5%) | −128.5 | −126.2 | 0.29 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 267 / 13414 (2.0%) | 8870 / 134140 (6.6%) | −128.4 | −126.2 | 0.30 |
| FOS SRX3322636 | MCF-7 Breast | 172 / 13414 (1.3%) | 7195 / 134140 (5.4%) | −128.2 | −126.0 | 0.24 |
| FOXA1 SRX11222437 | MCF-7 Breast | 200 / 13414 (1.5%) | 7703 / 134140 (5.7%) | −128.2 | −126.0 | 0.26 |
| JUNB SRX8488089 | SUM 229PE Breast | 290 / 13414 (2.2%) | 9242 / 134140 (6.9%) | −128.0 | −125.8 | 0.31 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 620 / 13414 (4.6%) | 14243 / 134140 (10.6%) | −127.9 | −125.7 | 0.44 |
| MEAF6 DRX300417 | 293 Kidney | 1212 / 13414 (9.0%) | 5372 / 134140 (4.0%) | −127.7 | −125.5 | 2.26 |
| ARID1A SRX5089379 | MCF-7 Breast | 282 / 13414 (2.1%) | 9093 / 134140 (6.8%) | −127.6 | −125.4 | 0.31 |
| FOXA1 SRX100506 | Hep G2 Liver | 383 / 13414 (2.9%) | 10711 / 134140 (8.0%) | −127.5 | −125.3 | 0.36 |
| BMI1 SRX7196715 | SU-DIPG-IV Neural | 1421 / 13414 (10.6%) | 6808 / 134140 (5.1%) | −127.5 | −125.3 | 2.09 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 245 / 13414 (1.8%) | 8464 / 134140 (6.3%) | −127.4 | −125.2 | 0.29 |
| SMARCA4 SRX5212362 | Mel270 Others | 501 / 13414 (3.7%) | 12495 / 134140 (9.3%) | −127.3 | −125.1 | 0.40 |
| JUNB SRX8488073 | SUM 229PE Breast | 549 / 13414 (4.1%) | 13196 / 134140 (9.8%) | −127.3 | −125.1 | 0.42 |
| MEAF6 SRX10606584 | GIST-T1 Digestive tract | 1235 / 13414 (9.2%) | 5547 / 134140 (4.1%) | −126.7 | −124.6 | 2.23 |
| AR SRX9469988 | LAPC-4 Prostate | 380 / 13414 (2.8%) | 10636 / 134140 (7.9%) | −126.7 | −124.5 | 0.36 |
| EP300 SRX027482 | hESC H9 Pluripotent stem cell | 240 / 13414 (1.8%) | 8357 / 134140 (6.2%) | −126.7 | −124.5 | 0.29 |
| AR SRX9109110 | MDA-MB-453 Breast | 548 / 13414 (4.1%) | 13154 / 134140 (9.8%) | −126.5 | −124.4 | 0.42 |
| ESR1 SRX371477 | MCF-7 Breast | 135 / 13414 (1.0%) | 6448 / 134140 (4.8%) | −126.5 | −124.3 | 0.21 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 615 / 13414 (4.6%) | 1776 / 134140 (1.3%) | −126.4 | −124.3 | 3.46 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 310 / 13414 (2.3%) | 9510 / 134140 (7.1%) | −126.3 | −124.1 | 0.33 |
| ESR1 SRX4451213 | MCF-7 Breast | 289 / 13414 (2.2%) | 9160 / 134140 (6.8%) | −126.1 | −123.9 | 0.32 |
| MECOM SRX23677885 | HNT-34 Blood | 1371 / 13414 (10.2%) | 6492 / 134140 (4.8%) | −126.0 | −123.9 | 2.11 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 254 / 13414 (1.9%) | 8569 / 134140 (6.4%) | −125.9 | −123.8 | 0.30 |
| EP300 SRX1012648 | MCF-7 Breast | 125 / 13414 (0.9%) | 6230 / 134140 (4.6%) | −125.9 | −123.7 | 0.20 |
| ESR1 SRX20282938 | MCF-7 Breast | 223 / 13414 (1.7%) | 8035 / 134140 (6.0%) | −125.8 | −123.6 | 0.28 |
| ESR1 SRX1469949 | MCF-7 Breast | 151 / 13414 (1.1%) | 6724 / 134140 (5.0%) | −125.5 | −123.3 | 0.22 |
| MECOM SRX23677884 | HNT-34 Blood | 1352 / 13414 (10.1%) | 6374 / 134140 (4.8%) | −125.4 | −123.2 | 2.12 |
| ESR1 SRX8537722 | MCF-7 Breast | 265 / 13414 (2.0%) | 8732 / 134140 (6.5%) | −125.2 | −123.0 | 0.30 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 976 / 13414 (7.3%) | 18987 / 134140 (14.2%) | −125.1 | −123.0 | 0.51 |
| GATAD2A SRX2636506 | Hep G2 Liver | 368 / 13414 (2.7%) | 10391 / 134140 (7.7%) | −125.1 | −122.9 | 0.35 |
| SS18 SRX3468047 | Fibroblasts Others | 745 / 13414 (5.6%) | 15879 / 134140 (11.8%) | −125.0 | −122.9 | 0.47 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 133 / 13414 (1.0%) | 6365 / 134140 (4.7%) | −125.0 | −122.9 | 0.21 |
| SMARCA4 SRX5212366 | Mel270 Others | 397 / 13414 (3.0%) | 10829 / 134140 (8.1%) | −124.8 | −122.6 | 0.37 |
| FOXA1 SRX11222442 | MCF-7 Breast | 185 / 13414 (1.4%) | 7327 / 134140 (5.5%) | −124.6 | −122.5 | 0.25 |
| STAT3 SRX2020842 | HCC70 Breast | 514 / 13414 (3.8%) | 12566 / 134140 (9.4%) | −124.2 | −122.0 | 0.41 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 263 / 13414 (2.0%) | 8663 / 134140 (6.5%) | −124.1 | −122.0 | 0.30 |
| ESR1 SRX20282959 | MCF-7 Breast | 101 / 13414 (0.8%) | 5693 / 134140 (4.2%) | −124.0 | −121.9 | 0.18 |
| ESR1 SRX10365533 | MCF-7 Breast | 128 / 13414 (1.0%) | 6236 / 134140 (4.6%) | −124.0 | −121.9 | 0.21 |
| PROX1 SRX3230397 | Hep G2 Liver | 200 / 13414 (1.5%) | 7570 / 134140 (5.6%) | −123.9 | −121.8 | 0.26 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 572 / 13414 (4.3%) | 13398 / 134140 (10.0%) | −123.8 | −121.7 | 0.43 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 273 / 13414 (2.0%) | 8811 / 134140 (6.6%) | −123.6 | −121.5 | 0.31 |
| JUNB SRX4192882 | MCF 10A Breast | 226 / 13414 (1.7%) | 8009 / 134140 (6.0%) | −123.5 | −121.3 | 0.28 |
| FOXA1 SRX3931055 | MCF-7 Breast | 243 / 13414 (1.8%) | 8301 / 134140 (6.2%) | −123.4 | −121.3 | 0.29 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 538 / 13414 (4.0%) | 1416 / 134140 (1.1%) | −123.4 | −121.3 | 3.80 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 273 / 13414 (2.0%) | 8803 / 134140 (6.6%) | −123.3 | −121.2 | 0.31 |
| JUNB SRX10119386 | MCF 10A Breast | 259 / 13414 (1.9%) | 8561 / 134140 (6.4%) | −123.1 | −121.0 | 0.30 |
| SMARCA4 SRX5212357 | Mel270 Others | 433 / 13414 (3.2%) | 11316 / 134140 (8.4%) | −123.0 | −120.9 | 0.38 |
| ESR1 SRX1012630 | MCF-7 Breast | 98 / 13414 (0.7%) | 5593 / 134140 (4.2%) | −122.7 | −120.6 | 0.18 |
| KMT2A SRX2323891 | 293 Kidney | 782 / 13414 (5.8%) | 2749 / 134140 (2.0%) | −122.7 | −120.5 | 2.84 |
| WWTR1 SRX10119367 | MCF 10A Breast | 343 / 13414 (2.6%) | 9902 / 134140 (7.4%) | −122.4 | −120.3 | 0.35 |
| FOXA1 SRX3931054 | MCF-7 Breast | 275 / 13414 (2.1%) | 8802 / 134140 (6.6%) | −122.3 | −120.2 | 0.31 |
| GATA3 SRX5457550 | MCF-7 Breast | 332 / 13414 (2.5%) | 9723 / 134140 (7.2%) | −122.3 | −120.2 | 0.34 |
| EP300 SRX150579 | HeLa Uterus | 188 / 13414 (1.4%) | 7302 / 134140 (5.4%) | −122.3 | −120.1 | 0.26 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 200 / 13414 (1.5%) | 7515 / 134140 (5.6%) | −122.2 | −120.1 | 0.27 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 588 / 13414 (4.4%) | 1683 / 134140 (1.3%) | −122.2 | −120.0 | 3.49 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 302 / 13414 (2.3%) | 9236 / 134140 (6.9%) | −122.1 | −120.0 | 0.33 |
| FOXA1 SRX1787651 | MCF-7 Breast | 159 / 13414 (1.2%) | 6765 / 134140 (5.0%) | −122.0 | −119.9 | 0.24 |
| FOXA2 SRX100448 | Hep G2 Liver | 325 / 13414 (2.4%) | 9602 / 134140 (7.2%) | −121.9 | −119.8 | 0.34 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 275 / 13414 (2.1%) | 8785 / 134140 (6.5%) | −121.9 | −119.8 | 0.31 |
| NANOG SRX20532161 | hESC HUES8 Pluripotent stem cell | 789 / 13414 (5.9%) | 16346 / 134140 (12.2%) | −121.9 | −119.8 | 0.48 |
| ESR1 SRX330068 | MCF-7 Breast | 127 / 13414 (0.9%) | 6151 / 134140 (4.6%) | −121.8 | −119.7 | 0.21 |
| GATA3 SRX6712581 | MCF-7 Breast | 238 / 13414 (1.8%) | 8156 / 134140 (6.1%) | −121.6 | −119.5 | 0.29 |
| SMARCA4 SRX8588624 | Pulmonary artery endothelial cells Cardiovascular | 526 / 13414 (3.9%) | 12642 / 134140 (9.4%) | −121.5 | −119.5 | 0.42 |
| SSRP1 SRX3436567 | HT-1080 Bone | 317 / 13414 (2.4%) | 471 / 134140 (0.4%) | −121.5 | −119.4 | 6.73 |
| MEAF6 SRX10606585 | GIST-T1 Digestive tract | 1342 / 13414 (10.0%) | 6393 / 134140 (4.8%) | −121.5 | −119.4 | 2.10 |
| FOXA1 SRX028634 | MCF-7 Breast | 135 / 13414 (1.0%) | 6293 / 134140 (4.7%) | −121.3 | −119.2 | 0.21 |
| Epitope tags SRX10549778 | K-562 Blood | 874 / 13414 (6.5%) | 3321 / 134140 (2.5%) | −121.3 | −119.2 | 2.63 |
| STAT3 SRX150479 | MCF 10A Breast | 271 / 13414 (2.0%) | 8693 / 134140 (6.5%) | −121.1 | −119.0 | 0.31 |
| STAT3 SRX150630 | MCF 10A Breast | 268 / 13414 (2.0%) | 8645 / 134140 (6.4%) | −121.0 | −119.0 | 0.31 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 614 / 13414 (4.6%) | 1834 / 134140 (1.4%) | −120.9 | −118.8 | 3.35 |
| MEAF6 SRX10606586 | GIST-T1 Digestive tract | 971 / 13414 (7.2%) | 3934 / 134140 (2.9%) | −120.8 | −118.7 | 2.47 |
| CDK9 SRX10131663 | Bronchial tracheal epithelial cells Lung | 852 / 13414 (6.4%) | 3195 / 134140 (2.4%) | −120.8 | −118.7 | 2.67 |
| ESR1 SRX3123829 | MCF-7 Breast | 162 / 13414 (1.2%) | 6783 / 134140 (5.1%) | −120.7 | −118.6 | 0.24 |
| FOXA1 SRX3923516 | MCF-7 Breast | 210 / 13414 (1.6%) | 7645 / 134140 (5.7%) | −120.7 | −118.6 | 0.27 |
| MECOM SRX23677897 | HNT-34 Blood | 1582 / 13414 (11.8%) | 8125 / 134140 (6.1%) | −120.7 | −118.6 | 1.95 |
| EP300 SRX1012644 | MCF-7 Breast | 121 / 13414 (0.9%) | 5992 / 134140 (4.5%) | −120.5 | −118.4 | 0.20 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 267 / 13414 (2.0%) | 8606 / 134140 (6.4%) | −120.4 | −118.3 | 0.31 |
| ERG SRX063922 | K-562 Blood | 1218 / 13414 (9.1%) | 5567 / 134140 (4.2%) | −120.3 | −118.2 | 2.19 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 685 / 13414 (5.1%) | 14851 / 134140 (11.1%) | −120.2 | −118.2 | 0.46 |
| FOXA1 SRX1787652 | MCF-7 Breast | 174 / 13414 (1.3%) | 6987 / 134140 (5.2%) | −120.2 | −118.1 | 0.25 |
| NR2F2 SRX190293 | MCF-7 Breast | 314 / 13414 (2.3%) | 9363 / 134140 (7.0%) | −120.1 | −118.0 | 0.34 |
| FOXA1 SRX5323843 | MCF-7 Breast | 149 / 13414 (1.1%) | 6510 / 134140 (4.9%) | −119.8 | −117.7 | 0.23 |
| FOXA1 SRX1787655 | MCF-7 Breast | 141 / 13414 (1.1%) | 6356 / 134140 (4.7%) | −119.7 | −117.6 | 0.22 |
| ESR1 SRX2912055 | MCF-7 Breast | 102 / 13414 (0.8%) | 5584 / 134140 (4.2%) | −119.5 | −117.4 | 0.18 |
| NR1H3 SRX1538760 | HT-29 Digestive tract | 281 / 13414 (2.1%) | 8787 / 134140 (6.6%) | −119.0 | −116.9 | 0.32 |
| ESR1 SRX1012633 | MCF-7 Breast | 142 / 13414 (1.1%) | 6352 / 134140 (4.7%) | −118.8 | −116.8 | 0.22 |
| EP300 SRX1012643 | MCF-7 Breast | 95 / 13414 (0.7%) | 5418 / 134140 (4.0%) | −118.7 | −116.6 | 0.18 |
| SOX2 SRX2731713 | Lung cancer cell line Lung | 179 / 13414 (1.3%) | 87 / 134140 (0.1%) | −118.7 | −116.6 | 20.57 |
| SOX13 SRX2636248 | Hep G2 Liver | 407 / 13414 (3.0%) | 10765 / 134140 (8.0%) | −118.7 | −116.6 | 0.38 |
| ESR1 SRX11120903 | MCF-7 Breast | 257 / 13414 (1.9%) | 8378 / 134140 (6.2%) | −118.6 | −116.6 | 0.31 |
| NANOG SRX20532160 | hESC HUES8 Pluripotent stem cell | 894 / 13414 (6.7%) | 17605 / 134140 (13.1%) | −118.4 | −116.3 | 0.51 |
| CDYL2 SRX8321653 | MCF-7 Breast | 1399 / 13414 (10.4%) | 6870 / 134140 (5.1%) | −118.2 | −116.1 | 2.04 |
| RELA SRX5938177 | FaDu Others | 270 / 13414 (2.0%) | 8576 / 134140 (6.4%) | −118.1 | −116.0 | 0.31 |
| ESR1 SRX8537723 | MCF-7 Breast | 239 / 13414 (1.8%) | 8058 / 134140 (6.0%) | −118.0 | −116.0 | 0.30 |
| NKX2-1 SRX2164786 | A549 Lung | 494 / 13414 (3.7%) | 12039 / 134140 (9.0%) | −118.0 | −115.9 | 0.41 |
| EP300 SRX2671792 | Cardiac progenitor cells Cardiovascular | 216 / 13414 (1.6%) | 7658 / 134140 (5.7%) | −117.8 | −115.8 | 0.28 |
| AR SRX9109113 | MDA-MB-453 Breast | 581 / 13414 (4.3%) | 13284 / 134140 (9.9%) | −117.7 | −115.6 | 0.44 |
| CEBPB SRX190345 | MCF-7 Breast | 229 / 13414 (1.7%) | 7873 / 134140 (5.9%) | −117.6 | −115.6 | 0.29 |
| JUN SRX17561461 | LPS141 Adipocyte | 445 / 13414 (3.3%) | 11296 / 134140 (8.4%) | −117.5 | −115.5 | 0.39 |
| NR3C1 SRX19024866 | MCF-7 Breast | 92 / 13414 (0.7%) | 5310 / 134140 (4.0%) | −117.3 | −115.2 | 0.17 |
| SMARCA4 SRX5212371 | Mel270 Others | 434 / 13414 (3.2%) | 11120 / 134140 (8.3%) | −117.2 | −115.2 | 0.39 |
| NANOG SRX10445309 | Neural crest cells Neural | 157 / 13414 (1.2%) | 6570 / 134140 (4.9%) | −116.7 | −114.7 | 0.24 |
| FOXA1 SRX3923517 | MCF-7 Breast | 212 / 13414 (1.6%) | 7550 / 134140 (5.6%) | −116.7 | −114.7 | 0.28 |
| SMARCA4 SRX8588623 | Pulmonary artery endothelial cells Cardiovascular | 435 / 13414 (3.2%) | 11106 / 134140 (8.3%) | −116.5 | −114.4 | 0.39 |
| CEBPA SRX2630241 | Hep G2 Liver | 369 / 13414 (2.8%) | 10098 / 134140 (7.5%) | −116.4 | −114.4 | 0.37 |
| TAL1 SRX393518 | Primary endothelial cells Cardiovascular | 438 / 13414 (3.3%) | 11146 / 134140 (8.3%) | −116.4 | −114.3 | 0.39 |
| AR SRX1067067 | LHSAR Prostate | 518 / 13414 (3.9%) | 12319 / 134140 (9.2%) | −116.2 | −114.2 | 0.42 |
| FOXA1 SRX11222438 | MCF-7 Breast | 157 / 13414 (1.2%) | 6550 / 134140 (4.9%) | −116.1 | −114.1 | 0.24 |
| FOXA1 SRX15430999 | T-47D Breast | 339 / 13414 (2.5%) | 9619 / 134140 (7.2%) | −116.0 | −114.0 | 0.35 |
| ESR1 SRX1469951 | MCF-7 Breast | 147 / 13414 (1.1%) | 6357 / 134140 (4.7%) | −115.8 | −113.8 | 0.23 |
| MECOM SRX23677896 | HNT-34 Blood | 1617 / 13414 (12.1%) | 8513 / 134140 (6.3%) | −115.6 | −113.6 | 1.90 |
| FOXA1 SRX3923518 | MCF-7 Breast | 209 / 13414 (1.6%) | 7455 / 134140 (5.6%) | −115.4 | −113.4 | 0.28 |
| ESR1 SRX1531796 | MCF-7 Breast | 155 / 13414 (1.2%) | 6486 / 134140 (4.8%) | −115.2 | −113.2 | 0.24 |
| ERG SRX063921 | K-562 Blood | 1148 / 13414 (8.6%) | 5202 / 134140 (3.9%) | −115.2 | −113.1 | 2.21 |
| PTEN SRX5416007 | SMMC-7721 Liver | 1367 / 13414 (10.2%) | 6725 / 134140 (5.0%) | −114.9 | −112.9 | 2.03 |
| ESR1 SRX4451212 | MCF-7 Breast | 289 / 13414 (2.2%) | 8767 / 134140 (6.5%) | −114.6 | −112.6 | 0.33 |
| JUNB SRX10119383 | MCF 10A Breast | 205 / 13414 (1.5%) | 7362 / 134140 (5.5%) | −114.5 | −112.5 | 0.28 |
| ESR1 SRX2943589 | MCF-7 Breast | 149 / 13414 (1.1%) | 6351 / 134140 (4.7%) | −114.5 | −112.5 | 0.23 |
| BMI1 SRX644729 | 293 Kidney | 190 / 13414 (1.4%) | 121 / 134140 (0.1%) | −114.4 | −112.4 | 15.70 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 287 / 13414 (2.1%) | 8717 / 134140 (6.5%) | −114.1 | −112.1 | 0.33 |
| NABP2 SRX9523535 | HT-1080 Bone | 1061 / 13414 (7.9%) | 4643 / 134140 (3.5%) | −114.1 | −112.0 | 2.29 |
| ESR1 SRX1012631 | MCF-7 Breast | 124 / 13414 (0.9%) | 5862 / 134140 (4.4%) | −114.0 | −112.0 | 0.21 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 249 / 13414 (1.9%) | 8083 / 134140 (6.0%) | −113.8 | −111.8 | 0.31 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 197 / 13414 (1.5%) | 7197 / 134140 (5.4%) | −113.7 | −111.7 | 0.27 |
| ESR1 SRX2513521 | MCF-7 Breast | 137 / 13414 (1.0%) | 6100 / 134140 (4.5%) | −113.7 | −111.7 | 0.22 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 970 / 13414 (7.2%) | 18396 / 134140 (13.7%) | −113.7 | −111.7 | 0.53 |
| STAT3 SRX150536 | MCF 10A Breast | 346 / 13414 (2.6%) | 9643 / 134140 (7.2%) | −113.6 | −111.6 | 0.36 |
| ZEB1 SRX13298925 | MCF-7 Breast | 180 / 13414 (1.3%) | 6891 / 134140 (5.1%) | −113.6 | −111.6 | 0.26 |
| HMG20A SRX2630163 | Hep G2 Liver | 164 / 13414 (1.2%) | 6599 / 134140 (4.9%) | −113.6 | −111.6 | 0.25 |
| ARID5B SRX3230377 | Hep G2 Liver | 763 / 13414 (5.7%) | 15638 / 134140 (11.7%) | −113.5 | −111.5 | 0.49 |
| EP300 SRX176885 | MCF-7 Breast | 154 / 13414 (1.1%) | 6416 / 134140 (4.8%) | −113.5 | −111.5 | 0.24 |
| ESR1 SRX2513517 | MCF-7 Breast | 201 / 13414 (1.5%) | 7253 / 134140 (5.4%) | −113.4 | −111.4 | 0.28 |
| ARID1A SRX5089385 | MCF-7 Breast | 227 / 13414 (1.7%) | 7690 / 134140 (5.7%) | −113.0 | −111.0 | 0.30 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 608 / 13414 (4.5%) | 13477 / 134140 (10.0%) | −113.0 | −111.0 | 0.45 |
| FOXA1 SRX1447317 | MCF-7 Breast | 197 / 13414 (1.5%) | 7163 / 134140 (5.3%) | −112.7 | −110.8 | 0.28 |
| NANOG SRX10448024 | hESC H1 Pluripotent stem cell | 1084 / 13414 (8.1%) | 19826 / 134140 (14.8%) | −112.7 | −110.8 | 0.55 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 419 / 13414 (3.1%) | 949 / 134140 (0.7%) | −112.7 | −110.7 | 4.42 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 405 / 13414 (3.0%) | 10515 / 134140 (7.8%) | −112.7 | −110.7 | 0.39 |
| Epitope tags SRX392691 | T3M-1 Cl-10 Others | 167 / 13414 (1.2%) | 77 / 134140 (0.1%) | −112.6 | −110.7 | 21.69 |
| CDK9 SRX7366783 | MCF-7 Breast | 192 / 13414 (1.4%) | 131 / 134140 (0.1%) | −112.4 | −110.5 | 14.66 |
| TFAP2C SRX018833 | MCF-7 Breast | 277 / 13414 (2.1%) | 8501 / 134140 (6.3%) | −112.4 | −110.4 | 0.33 |
| FOXA1 SRX1161203 | T-47D Breast | 220 / 13414 (1.6%) | 7544 / 134140 (5.6%) | −112.3 | −110.3 | 0.29 |
| FOXA1 SRX028635 | MCF-7 Breast | 151 / 13414 (1.1%) | 6310 / 134140 (4.7%) | −111.9 | −110.0 | 0.24 |
| ESR1 SRX1012628 | MCF-7 Breast | 152 / 13414 (1.1%) | 6326 / 134140 (4.7%) | −111.9 | −109.9 | 0.24 |
| TFAP2C SRX128099 | MCF-7 Breast | 278 / 13414 (2.1%) | 8496 / 134140 (6.3%) | −111.9 | −109.9 | 0.33 |
| VGLL1 SRX18013277 | FULVR Breast | 124 / 13414 (0.9%) | 5797 / 134140 (4.3%) | −111.9 | −109.9 | 0.21 |
| BMI1 SRX7196721 | SF8628 Neural | 1296 / 13414 (9.7%) | 6299 / 134140 (4.7%) | −111.8 | −109.8 | 2.06 |
| ARID5B SRX10475139 | Hep G2 Liver | 334 / 13414 (2.5%) | 9388 / 134140 (7.0%) | −111.8 | −109.8 | 0.36 |
| AR SRX1067066 | LHSAR Prostate | 654 / 13414 (4.9%) | 14069 / 134140 (10.5%) | −111.7 | −109.7 | 0.46 |
| YAP1 SRX10119364 | MCF 10A Breast | 263 / 13414 (2.0%) | 8248 / 134140 (6.1%) | −111.7 | −109.7 | 0.32 |
| EP300 SRX2194266 | SUM 159PT Breast | 545 / 13414 (4.1%) | 12530 / 134140 (9.3%) | −111.7 | −109.7 | 0.43 |
| JUND SRX150408 | HeLa Uterus | 275 / 13414 (2.1%) | 8441 / 134140 (6.3%) | −111.6 | −109.7 | 0.33 |
| EP300 SRX717859 | HeLa Uterus | 159 / 13414 (1.2%) | 6445 / 134140 (4.8%) | −111.5 | −109.6 | 0.25 |
| FOXA2 SRX10475773 | Hep G2 Liver | 377 / 13414 (2.8%) | 10039 / 134140 (7.5%) | −111.3 | −109.4 | 0.38 |
| ESR1 SRX2513520 | MCF-7 Breast | 188 / 13414 (1.4%) | 6953 / 134140 (5.2%) | −111.2 | −109.2 | 0.27 |
| JUND SRX190357 | SK-N-SH Neural | 400 / 13414 (3.0%) | 10376 / 134140 (7.7%) | −111.1 | −109.1 | 0.39 |
| JUNB SRX8488074 | SUM 229PE Breast | 420 / 13414 (3.1%) | 10675 / 134140 (8.0%) | −111.0 | −109.0 | 0.39 |
| WDR5 SRX5416008 | SMMC-7721 Liver | 1354 / 13414 (10.1%) | 6728 / 134140 (5.0%) | −110.9 | −109.0 | 2.01 |
| FOXA1 SRX15430987 | MDA-MB-453 Breast | 459 / 13414 (3.4%) | 11240 / 134140 (8.4%) | −110.5 | −108.6 | 0.41 |
| EP300 SRX176883 | MCF-7 Breast | 138 / 13414 (1.0%) | 6022 / 134140 (4.5%) | −110.4 | −108.5 | 0.23 |
| FOXA1 SRX5203303 | MCF-7 Breast | 101 / 13414 (0.8%) | 5301 / 134140 (4.0%) | −110.4 | −108.4 | 0.19 |
| FOXA2 SRX6441755 | CFPAC-1 Pancreas | 241 / 13414 (1.8%) | 7838 / 134140 (5.8%) | −110.3 | −108.4 | 0.31 |
| PRRX1 SRX15235713 | Hs 578T Breast | 379 / 13414 (2.8%) | 10030 / 134140 (7.5%) | −110.3 | −108.3 | 0.38 |
| Epitope tags SRX392692 | T3M-1 Cl-10 Others | 159 / 13414 (1.2%) | 67 / 134140 (0.0%) | −110.3 | −108.3 | 23.73 |
| ZFX SRX7805372 | 293 Kidney | 1194 / 13414 (8.9%) | 5629 / 134140 (4.2%) | −110.1 | −108.1 | 2.12 |
| ESR1 SRX2881001 | MCF-7 Breast | 167 / 13414 (1.2%) | 6541 / 134140 (4.9%) | −110.0 | −108.0 | 0.26 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 207 / 13414 (1.5%) | 7245 / 134140 (5.4%) | −109.9 | −107.9 | 0.29 |
| ARID1A SRX5089391 | MCF-7 Breast | 170 / 13414 (1.3%) | 6591 / 134140 (4.9%) | −109.8 | −107.8 | 0.26 |
| FOXA1 SRX3931033 | MCF-7 Breast | 199 / 13414 (1.5%) | 7105 / 134140 (5.3%) | −109.8 | −107.8 | 0.28 |
| OTX2 SRX702045 | hESC HUES64 Pluripotent stem cell | 236 / 13414 (1.8%) | 7729 / 134140 (5.8%) | −109.6 | −107.7 | 0.31 |
| FOXA2 SRX6441754 | CFPAC-1 Pancreas | 233 / 13414 (1.7%) | 7673 / 134140 (5.7%) | −109.4 | −107.5 | 0.30 |
| ESR1 SRX4451214 | MCF-7 Breast | 273 / 13414 (2.0%) | 8328 / 134140 (6.2%) | −109.3 | −107.4 | 0.33 |
| PBX3 SRX190343 | SK-N-SH Neural | 656 / 13414 (4.9%) | 13991 / 134140 (10.4%) | −109.2 | −107.2 | 0.47 |
| ESR1 SRX1161186 | ZR-75-1 Breast | 95 / 13414 (0.7%) | 5141 / 134140 (3.8%) | −109.1 | −107.2 | 0.18 |
| Epitope tags SRX8080558 | Mammary gland adenocarcinoma Breast | 109 / 13414 (0.8%) | 5422 / 134140 (4.0%) | −109.1 | −107.2 | 0.20 |
| FOXA1 SRX1447316 | MCF-7 Breast | 128 / 13414 (1.0%) | 5790 / 134140 (4.3%) | −109.0 | −107.1 | 0.22 |
| FOXL2 SRX6957431 | KGN Gonad | 724 / 13414 (5.4%) | 14912 / 134140 (11.1%) | −108.8 | −106.9 | 0.49 |
| FOXA1 SRX1961157 | T-47D Breast | 347 / 13414 (2.6%) | 9478 / 134140 (7.1%) | −108.6 | −106.7 | 0.37 |
| ESR1 SRX1012625 | MCF-7 Breast | 163 / 13414 (1.2%) | 6427 / 134140 (4.8%) | −108.6 | −106.7 | 0.25 |
| FOXA1 SRX3923519 | MCF-7 Breast | 190 / 13414 (1.4%) | 6902 / 134140 (5.1%) | −108.5 | −106.5 | 0.28 |
| FOXA1 SRX100477 | Hep G2 Liver | 361 / 13414 (2.7%) | 9684 / 134140 (7.2%) | −108.3 | −106.4 | 0.37 |
| MED1 SRX4937338 | HCT 116 Digestive tract | 1083 / 13414 (8.1%) | 4911 / 134140 (3.7%) | −108.3 | −106.4 | 2.21 |
| ESR1 SRX3110720 | MCF-7 Breast | 123 / 13414 (0.9%) | 5672 / 134140 (4.2%) | −108.3 | −106.4 | 0.22 |
| DNA-RNA hybrid SRX14756935 | MDA-MB-436 Breast | 440 / 13414 (3.3%) | 1086 / 134140 (0.8%) | −108.3 | −106.3 | 4.05 |
| NFYB SRX16608147 | HeLa Uterus | 203 / 13414 (1.5%) | 172 / 134140 (0.1%) | −108.0 | −106.1 | 11.80 |
| SOX5 SRX2636544 | Hep G2 Liver | 310 / 13414 (2.3%) | 8873 / 134140 (6.6%) | −107.9 | −106.0 | 0.35 |
| ARID1A SRX5089388 | MCF-7 Breast | 158 / 13414 (1.2%) | 6316 / 134140 (4.7%) | −107.9 | −106.0 | 0.25 |
| ESR1 SRX1995229 | MCF-7 Breast | 319 / 13414 (2.4%) | 9012 / 134140 (6.7%) | −107.8 | −105.9 | 0.35 |
| NR3C1 SRX2609664 | HASM2 Lung | 446 / 13414 (3.3%) | 10935 / 134140 (8.2%) | −107.6 | −105.7 | 0.41 |
| ZFX SRX7805370 | 293 Kidney | 886 / 13414 (6.6%) | 3632 / 134140 (2.7%) | −107.6 | −105.7 | 2.44 |
| WWTR1 SRX10119378 | MCF 10A Breast | 346 / 13414 (2.6%) | 9425 / 134140 (7.0%) | −107.6 | −105.7 | 0.37 |
| GATAD2A SRX2636507 | Hep G2 Liver | 340 / 13414 (2.5%) | 9332 / 134140 (7.0%) | −107.5 | −105.6 | 0.36 |
| ESR1 SRX792933 | LY2 Breast | 264 / 13414 (2.0%) | 8122 / 134140 (6.1%) | −107.5 | −105.6 | 0.33 |
| FOXA1 SRX1961158 | T-47D Breast | 316 / 13414 (2.4%) | 8929 / 134140 (6.7%) | −106.9 | −104.9 | 0.35 |
| NR3C1 SRX19024870 | MCF-7 Breast | 101 / 13414 (0.8%) | 5197 / 134140 (3.9%) | −106.8 | −104.9 | 0.19 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 618 / 13414 (4.6%) | 13368 / 134140 (10.0%) | −106.8 | −104.9 | 0.46 |
| TP53 SRX2585782 | MDA-MB-231 Breast | 590 / 13414 (4.4%) | 12966 / 134140 (9.7%) | −106.6 | −104.7 | 0.46 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 897 / 13414 (6.7%) | 17114 / 134140 (12.8%) | −106.4 | −104.5 | 0.52 |
| SMARCA4 SRX027488 | hESC H9 Pluripotent stem cell | 81 / 13414 (0.6%) | 4767 / 134140 (3.6%) | −106.3 | −104.3 | 0.17 |
| FOXA1 SRX3923515 | MCF-7 Breast | 178 / 13414 (1.3%) | 6620 / 134140 (4.9%) | −106.1 | −104.2 | 0.27 |
| CDK9 SRX7366781 | MCF-7 Breast | 180 / 13414 (1.3%) | 121 / 134140 (0.1%) | −106.1 | −104.2 | 14.88 |
| NR3C1 SRX8520809 | SUM 159PT Breast | 278 / 13414 (2.1%) | 8296 / 134140 (6.2%) | −106.0 | −104.1 | 0.34 |
| CXXC1 SRX1424886 | SEM Blood | 1092 / 13414 (8.1%) | 5023 / 134140 (3.7%) | −105.9 | −104.0 | 2.17 |
| ESR1 SRX3110723 | MCF-7 Breast | 172 / 13414 (1.3%) | 6501 / 134140 (4.8%) | −105.7 | −103.8 | 0.26 |
| ESR1 SRX2897220 | Breast cancer cells Breast | 1181 / 13414 (8.8%) | 5643 / 134140 (4.2%) | −105.5 | −103.6 | 2.09 |
| GATA3 SRX100559 | T-47D Breast | 347 / 13414 (2.6%) | 9362 / 134140 (7.0%) | −105.5 | −103.6 | 0.37 |
| ESR1 SRX2513519 | MCF-7 Breast | 170 / 13414 (1.3%) | 6453 / 134140 (4.8%) | −105.4 | −103.5 | 0.26 |
| ESR1 SRX2513518 | MCF-7 Breast | 152 / 13414 (1.1%) | 6125 / 134140 (4.6%) | −105.4 | −103.5 | 0.25 |
| FOXA1 SRX5323829 | T-47D Breast | 178 / 13414 (1.3%) | 6589 / 134140 (4.9%) | −105.3 | −103.4 | 0.27 |
| NR1H3 SRX1538763 | HT-29 Digestive tract | 306 / 13414 (2.3%) | 8716 / 134140 (6.5%) | −105.3 | −103.4 | 0.35 |
| JUN SRX883584 | MDA-MB-231 Breast | 508 / 13414 (3.8%) | 11747 / 134140 (8.8%) | −105.2 | −103.3 | 0.43 |
| FOXA1 SRX3923531 | ZR-75-1 Breast | 181 / 13414 (1.3%) | 6637 / 134140 (4.9%) | −105.1 | −103.2 | 0.27 |
| ARID1A SRX5089382 | MCF-7 Breast | 230 / 13414 (1.7%) | 7476 / 134140 (5.6%) | −105.1 | −103.2 | 0.31 |
| NR3C1 SRX1161181 | ZR-75-1 Breast | 87 / 13414 (0.6%) | 4861 / 134140 (3.6%) | −105.1 | −103.2 | 0.18 |
| FOXL2 SRX6957477 | KGN Gonad | 338 / 13414 (2.5%) | 9204 / 134140 (6.9%) | −104.9 | −103.0 | 0.37 |
| NR3C1 SRX17639412 | A549 Lung | 361 / 13414 (2.7%) | 9554 / 134140 (7.1%) | −104.8 | −102.9 | 0.38 |
| FOXA1 SRX5323845 | MCF-7 Breast | 117 / 13414 (0.9%) | 5450 / 134140 (4.1%) | −104.8 | −102.9 | 0.21 |
| ESR1 SRX176856 | MCF-7 Breast | 107 / 13414 (0.8%) | 5257 / 134140 (3.9%) | −104.7 | −102.8 | 0.20 |
| NR3C1 SRX8520802 | HCC1187 Breast | 238 / 13414 (1.8%) | 7597 / 134140 (5.7%) | −104.7 | −102.8 | 0.31 |
| TEAD1 SRX14688734 | HUVEC Cardiovascular | 280 / 13414 (2.1%) | 8281 / 134140 (6.2%) | −104.6 | −102.7 | 0.34 |
| FOSL2 SRX5054309 | Neural progenitor cells Neural | 329 / 13414 (2.5%) | 9048 / 134140 (6.7%) | −104.5 | −102.6 | 0.36 |
| FOS SRX3322637 | MCF-7 Breast | 172 / 13414 (1.3%) | 6455 / 134140 (4.8%) | −104.3 | −102.4 | 0.27 |
| FOXA1 SRX3931056 | MCF-7 Breast | 194 / 13414 (1.4%) | 6838 / 134140 (5.1%) | −104.3 | −102.4 | 0.28 |
| FOXA1 SRX1161205 | T-47D Breast | 171 / 13414 (1.3%) | 6432 / 134140 (4.8%) | −104.2 | −102.3 | 0.27 |
| FOXA1 SRX5124036 | 22Rv1 Prostate | 343 / 13414 (2.6%) | 9253 / 134140 (6.9%) | −104.2 | −102.3 | 0.37 |
| TRP47 SRX4548329 | THP-1 Blood | 1911 / 13414 (14.2%) | 11093 / 134140 (8.3%) | −104.0 | −102.1 | 1.72 |
| TAZ SRX14181208 | MSK-PCa3 Prostate | 343 / 13414 (2.6%) | 9243 / 134140 (6.9%) | −103.9 | −102.0 | 0.37 |
| EP300 SRX2194265 | SUM 159PT Breast | 510 / 13414 (3.8%) | 11720 / 134140 (8.7%) | −103.8 | −101.9 | 0.44 |
| FOSL2 SRX190296 | SK-N-SH Neural | 441 / 13414 (3.3%) | 10714 / 134140 (8.0%) | −103.8 | −101.9 | 0.41 |
| MED1 SRX4937342 | HCT 116 Digestive tract | 1017 / 13414 (7.6%) | 4563 / 134140 (3.4%) | −103.6 | −101.8 | 2.23 |
| GFP SRX6949256 | HeLa Uterus | 356 / 13414 (2.7%) | 9434 / 134140 (7.0%) | −103.6 | −101.7 | 0.38 |
| EOMES SRX035159 | hESC derived mesendodermal cells Pluripotent stem cell | 219 / 13414 (1.6%) | 7241 / 134140 (5.4%) | −103.5 | −101.7 | 0.30 |
| NANOG SRX3288567 | hESC H9 Pluripotent stem cell | 111 / 13414 (0.8%) | 5301 / 134140 (4.0%) | −103.5 | −101.7 | 0.21 |
| JUNB SRX10119384 | MCF 10A Breast | 200 / 13414 (1.5%) | 6916 / 134140 (5.2%) | −103.5 | −101.6 | 0.29 |
| ESR1 SRX20282966 | MCF-7 Breast | 111 / 13414 (0.8%) | 5288 / 134140 (3.9%) | −103.3 | −101.4 | 0.21 |
| FOSL2 SRX3367141 | SK-MEL-147 Epidermis | 468 / 13414 (3.5%) | 11085 / 134140 (8.3%) | −103.2 | −101.3 | 0.42 |
| GATA2 SRX3503584 | Endometrial stromal cells Uterus | 361 / 13414 (2.7%) | 9491 / 134140 (7.1%) | −103.1 | −101.3 | 0.38 |
| FOXA1 SRX190181 | A549 Lung | 239 / 13414 (1.8%) | 7558 / 134140 (5.6%) | −103.1 | −101.2 | 0.32 |
| NKX2-1 SRX366169 | NCI-H441 Lung | 382 / 13414 (2.8%) | 9808 / 134140 (7.3%) | −103.0 | −101.1 | 0.39 |
| ESR1 SRX5323878 | MCF-7 Breast | 327 / 13414 (2.4%) | 8961 / 134140 (6.7%) | −102.9 | −101.0 | 0.36 |
| SMARCA4 SRX8588626 | Pulmonary artery endothelial cells Cardiovascular | 441 / 13414 (3.3%) | 10683 / 134140 (8.0%) | −102.9 | −101.0 | 0.41 |
| FOS SRX070879 | HUVEC Cardiovascular | 356 / 13414 (2.7%) | 9405 / 134140 (7.0%) | −102.8 | −101.0 | 0.38 |
| AR SRX15946405 | MDA-MB-453 Breast | 206 / 13414 (1.5%) | 6997 / 134140 (5.2%) | −102.8 | −101.0 | 0.29 |
| ESR1 SRX10365534 | MCF-7 Breast | 96 / 13414 (0.7%) | 4978 / 134140 (3.7%) | −102.8 | −100.9 | 0.19 |
| EP300 SRX717860 | HeLa Uterus | 207 / 13414 (1.5%) | 7014 / 134140 (5.2%) | −102.8 | −100.9 | 0.30 |
| ESR1 SRX5534831 | MCF-7 Breast | 254 / 13414 (1.9%) | 7793 / 134140 (5.8%) | −102.8 | −100.9 | 0.33 |
| ING2 SRX286201 | RKO Digestive tract | 1056 / 13414 (7.9%) | 4847 / 134140 (3.6%) | −102.8 | −100.9 | 2.18 |
| ESR1 SRX5323873 | MCF-7 Breast | 407 / 13414 (3.0%) | 10174 / 134140 (7.6%) | −102.7 | −100.9 | 0.40 |
| ESR1 SRX3123830 | MCF-7 Breast | 84 / 13414 (0.6%) | 4731 / 134140 (3.5%) | −102.6 | −100.8 | 0.18 |
| EP300 SRX2671813 | Fibroblasts Others | 276 / 13414 (2.1%) | 8147 / 134140 (6.1%) | −102.6 | −100.8 | 0.34 |
| RORC SRX5359052 | HCC70 Breast | 957 / 13414 (7.1%) | 4187 / 134140 (3.1%) | −102.6 | −100.7 | 2.29 |
| NANOG SRX017277 | hESC H1 Pluripotent stem cell | 124 / 13414 (0.9%) | 5515 / 134140 (4.1%) | −102.5 | −100.6 | 0.22 |
| AR SRX11149848 | MDA-MB-453 Breast | 207 / 13414 (1.5%) | 7001 / 134140 (5.2%) | −102.4 | −100.5 | 0.30 |
| ESR1 SRX5323871 | MCF-7 Breast | 359 / 13414 (2.7%) | 9432 / 134140 (7.0%) | −102.4 | −100.5 | 0.38 |
| FOXA1 SRX3923530 | ZR-75-1 Breast | 214 / 13414 (1.6%) | 7113 / 134140 (5.3%) | −102.3 | −100.4 | 0.30 |
| DAXX SRX1021630 | PC-3 Prostate | 333 / 13414 (2.5%) | 9030 / 134140 (6.7%) | −102.3 | −100.4 | 0.37 |
| NANOG SRX5286326 | hESC WIBR2 Pluripotent stem cell | 278 / 13414 (2.1%) | 8163 / 134140 (6.1%) | −102.2 | −100.4 | 0.34 |
| MECOM SRX23677890 | HNT-34 Blood | 1338 / 13414 (10.0%) | 6837 / 134140 (5.1%) | −102.2 | −100.3 | 1.96 |
| NFIL3 SRX2630334 | Hep G2 Liver | 256 / 13414 (1.9%) | 7805 / 134140 (5.8%) | −102.1 | −100.2 | 0.33 |
| ESR1 SRX1995230 | MCF-7 Breast | 285 / 13414 (2.1%) | 8268 / 134140 (6.2%) | −102.0 | −100.2 | 0.34 |
| FOXA1 SRX6878603 | LNCAP Prostate | 363 / 13414 (2.7%) | 9480 / 134140 (7.1%) | −102.0 | −100.2 | 0.38 |
| SSRP1 SRX3436566 | HT-1080 Bone | 230 / 13414 (1.7%) | 274 / 134140 (0.2%) | −102.0 | −100.1 | 8.39 |
| FOXA2 SRX5504126 | CFPAC-1 Pancreas | 212 / 13414 (1.6%) | 7067 / 134140 (5.3%) | −101.9 | −100.1 | 0.30 |
| FOXA2 SRX11650944 | hESC derived pancreatic cells Pluripotent stem cell | 288 / 13414 (2.1%) | 8303 / 134140 (6.2%) | −101.6 | −99.8 | 0.35 |
| SMARCC1 SRX11379511 | Liposarcoma, Myxoid Adipocyte | 449 / 13414 (3.3%) | 10738 / 134140 (8.0%) | −101.4 | −99.5 | 0.42 |
| FOSL2 SRX190204 | A549 Lung | 331 / 13414 (2.5%) | 8969 / 134140 (6.7%) | −101.4 | −99.5 | 0.37 |
| GATA2 SRX16314543 | Trophoblast stem cells Placenta | 301 / 13414 (2.2%) | 8488 / 134140 (6.3%) | −101.1 | −99.2 | 0.35 |
| FOXA1 SRX5323846 | MCF-7 Breast | 125 / 13414 (0.9%) | 5490 / 134140 (4.1%) | −101.0 | −99.2 | 0.23 |
| Crotonyllysine SRX19488269 | GSC23 Neural | 910 / 13414 (6.8%) | 3912 / 134140 (2.9%) | −100.9 | −99.1 | 2.33 |
| CBX3 SRX6712570 | MCF-7 Breast | 261 / 13414 (1.9%) | 7843 / 134140 (5.8%) | −100.9 | −99.1 | 0.33 |
| KAT7 DRX234808 | 293 Kidney | 574 / 13414 (4.3%) | 1864 / 134140 (1.4%) | −100.8 | −99.0 | 3.08 |
| FOXA1 SRX5203307 | MCF-7 Breast | 98 / 13414 (0.7%) | 4960 / 134140 (3.7%) | −100.7 | −98.8 | 0.20 |
| RUNX1 SRX2014504 | Jurkat Blood | 1777 / 13414 (13.2%) | 10167 / 134140 (7.6%) | −100.6 | −98.8 | 1.75 |
| TRIM25 SRX1660872 | Breast cancer cells Breast | 1223 / 13414 (9.1%) | 6059 / 134140 (4.5%) | −100.5 | −98.6 | 2.02 |
| NR3C1 SRX10976921 | A549 Lung | 235 / 13414 (1.8%) | 7402 / 134140 (5.5%) | −100.4 | −98.5 | 0.32 |
| ESR1 SRX2922232 | SUM 44PE Breast | 135 / 13414 (1.0%) | 5657 / 134140 (4.2%) | −100.4 | −98.5 | 0.24 |
| ESR1 SRX5323872 | MCF-7 Breast | 335 / 13414 (2.5%) | 8991 / 134140 (6.7%) | −100.4 | −98.5 | 0.37 |
| FOXA1 SRX5323830 | T-47D Breast | 197 / 13414 (1.5%) | 6761 / 134140 (5.0%) | −100.3 | −98.5 | 0.29 |
| FOXA1 SRX5203294 | MCF-7 Breast | 96 / 13414 (0.7%) | 4906 / 134140 (3.7%) | −100.3 | −98.5 | 0.20 |
| FOXA1 SRX6860635 | T-47D Breast | 257 / 13414 (1.9%) | 7756 / 134140 (5.8%) | −100.3 | −98.5 | 0.33 |
| ZEB1 SRX13298923 | MCF-7 Breast | 136 / 13414 (1.0%) | 5675 / 134140 (4.2%) | −100.3 | −98.5 | 0.24 |
| RTF1 SRX15147196 | DLD-1 Digestive tract | 504 / 13414 (3.8%) | 1492 / 134140 (1.1%) | −100.2 | −98.4 | 3.38 |
| FOXA1 SRX15430988 | MDA-MB-453 Breast | 339 / 13414 (2.5%) | 9043 / 134140 (6.7%) | −100.1 | −98.3 | 0.37 |
| EP300 SRX2671820 | iPS cells Pluripotent stem cell | 72 / 13414 (0.5%) | 4404 / 134140 (3.3%) | −100.0 | −98.2 | 0.16 |
| FOXA1 SRX3931032 | MCF-7 Breast | 198 / 13414 (1.5%) | 6767 / 134140 (5.0%) | −100.0 | −98.2 | 0.29 |
| MAU2 SRX11120892 | MCF-7 Breast | 137 / 13414 (1.0%) | 5683 / 134140 (4.2%) | −99.9 | −98.1 | 0.24 |
| INTS3 SRX3640569 | HeLa Uterus | 947 / 13414 (7.1%) | 4174 / 134140 (3.1%) | −99.9 | −98.1 | 2.27 |
| NR3C1 SRX9298951 | Lung cancer cell line Lung | 216 / 13414 (1.6%) | 7068 / 134140 (5.3%) | −99.9 | −98.0 | 0.31 |
| FOXA2 SRX2368889 | Ker-CT Epidermis | 274 / 13414 (2.0%) | 8015 / 134140 (6.0%) | −99.8 | −98.0 | 0.34 |
| YAP1 SRX10119388 | MDA-MB-231 Breast | 237 / 13414 (1.8%) | 7416 / 134140 (5.5%) | −99.8 | −98.0 | 0.32 |
| JUN SRX6582163 | BJ-5ta Epidermis | 424 / 13414 (3.2%) | 10309 / 134140 (7.7%) | −99.7 | −97.9 | 0.41 |
| MAU2 SRX11120893 | MCF-7 Breast | 129 / 13414 (1.0%) | 5524 / 134140 (4.1%) | −99.7 | −97.8 | 0.23 |
| LEO1 SRX15147190 | DLD-1 Digestive tract | 646 / 13414 (4.8%) | 2293 / 134140 (1.7%) | −99.6 | −97.7 | 2.82 |
| NR3C1 SRX1161167 | MCF-7 Breast | 83 / 13414 (0.6%) | 4618 / 134140 (3.4%) | −99.5 | −97.7 | 0.18 |
| PGR SRX1012654 | MCF-7 Breast | 112 / 13414 (0.8%) | 5199 / 134140 (3.9%) | −99.5 | −97.7 | 0.22 |
| STAT3 SRX2020847 | MDA-MB-468 Breast | 232 / 13414 (1.7%) | 7321 / 134140 (5.5%) | −99.5 | −97.7 | 0.32 |
Showing first 500 of 17089 rows.